Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez
28/04/2025 13:11
April 28 (Reuters) - Appili Therapeutics Inc APLI.TO: APPILI THERAPEUTICS ANNOUNCES NEW PATENTS GRANTED FOR COMMERCIAL STAGE ASSET LIKMEZ®™ APPILI THERAPEUTICS INC - PATENTS FOR LIKMEZ TO EXPIRE IN 2039 APPILI THERAPEUTICS INC - U.S. PATENT FOR LIKMEZ LISTED IN FDA ORANGE BOOK Source text: ID:nGNX4p54bf Further company coverage: APLI.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez